DE602005002836D1 - Diagnoseverfahren für erkrankungen unter verwendung von copeptin - Google Patents

Diagnoseverfahren für erkrankungen unter verwendung von copeptin

Info

Publication number
DE602005002836D1
DE602005002836D1 DE200560002836 DE602005002836T DE602005002836D1 DE 602005002836 D1 DE602005002836 D1 DE 602005002836D1 DE 200560002836 DE200560002836 DE 200560002836 DE 602005002836 T DE602005002836 T DE 602005002836T DE 602005002836 D1 DE602005002836 D1 DE 602005002836D1
Authority
DE
Germany
Prior art keywords
copeptin
illnesses
diagnostic procedure
diagnostic
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE200560002836
Other languages
English (en)
Other versions
DE602005002836T2 (de
Inventor
Andreas Bergmann
Joachim Struck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BRAHMS GmbH
Original Assignee
BRAHMS GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BRAHMS GmbH filed Critical BRAHMS GmbH
Publication of DE602005002836D1 publication Critical patent/DE602005002836D1/de
Application granted granted Critical
Publication of DE602005002836T2 publication Critical patent/DE602005002836T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5757—Vasoactive intestinal peptide [VIP] or related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE200560002836 2004-08-19 2005-08-19 Diagnoseverfahren für erkrankungen unter verwendung von copeptin Active DE602005002836T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04019732 2004-08-19
EP20040019732 EP1628136A1 (de) 2004-08-19 2004-08-19 Diagnoseverfahren für Krankheiten unter Verwendung von Copeptin
PCT/EP2005/009001 WO2006018315A1 (en) 2004-08-19 2005-08-19 Diagnostic method for disorders using copeptin

Publications (2)

Publication Number Publication Date
DE602005002836D1 true DE602005002836D1 (de) 2007-11-22
DE602005002836T2 DE602005002836T2 (de) 2008-07-31

Family

ID=34926232

Family Applications (1)

Application Number Title Priority Date Filing Date
DE200560002836 Active DE602005002836T2 (de) 2004-08-19 2005-08-19 Diagnoseverfahren für erkrankungen unter verwendung von copeptin

Country Status (11)

Country Link
US (3) US7807397B2 (de)
EP (2) EP1628136A1 (de)
JP (2) JP4932714B2 (de)
CN (2) CN101010591B (de)
AR (1) AR050215A1 (de)
AT (1) ATE375518T1 (de)
DE (1) DE602005002836T2 (de)
ES (1) ES2296224T3 (de)
HK (2) HK1114171A1 (de)
MX (1) MXPA06014775A (de)
WO (1) WO2006018315A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140046407A1 (en) * 2001-08-31 2014-02-13 Bio Control Medical (B.C.M.) Ltd. Nerve stimulation techniques
DE102006034142A1 (de) 2006-07-24 2008-01-31 B.R.A.H.M.S. Aktiengesellschaft Verfahren zur Steuerung der Therapie von Patienten mit Herzinsuffizienz anhand der vitro Bestimmung von Schwellenwerten von vasoaktiven Peptiden
DE102006046996A1 (de) * 2006-10-01 2008-04-03 Brahms Aktiengesellschaft Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz
US9285362B2 (en) * 2006-10-18 2016-03-15 Axela, Inc. Measuring multiple analytes over a broad range of concentrations using optical diffraction
DE102006050497A1 (de) * 2006-10-26 2008-04-30 Brahms Aktiengesellschaft Risikostratifizierung des akuten Koronarsyndroms mittels Fragmenten / Teilpeptiden des proVasopressins, insbesondere Copeptin oder Neurophysin II
WO2008049422A2 (de) * 2006-10-26 2008-05-02 Brahms Aktiengesellschaft Risikostratifizierung des akuten koronarsyndroms mittels fragmenten / teilpeptiden des provasopressins, insbesondere copeptin oder neurophysin ii
DE102006053442A1 (de) * 2006-11-12 2008-05-15 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Infektionen und chronischen Erkrankungen der Atemwege und Lunge mittels proVasopressin, insbesondere Copeptin oder Neurophysin II
DE102006058266A1 (de) * 2006-12-08 2008-06-12 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Herzinsuffizienz mittels Neurophysin
EP2180322A1 (de) * 2008-10-22 2010-04-28 BRAHMS Aktiengesellschaft Prognostische Biomarker zur Progression von primär chronischen Nierenerkrankungen
EP2356463B1 (de) * 2008-10-31 2017-08-30 B.R.A.H.M.S GmbH Arginin-vasopressin-prohormon als vorhersagender biomarker für diabetes
US20100312581A1 (en) * 2009-06-08 2010-12-09 Peter James Wachtell Process and system for efficient allocation of medical resources
CN102482343A (zh) 2009-06-16 2012-05-30 B.R.A.H.M.S有限公司 过氧化物氧还蛋白4的诊断应用
EP2583103B1 (de) * 2010-06-18 2016-04-20 B.R.A.H.M.S GmbH Biomarker zur Vorhersage der Inzidenz von Krebs
ES2642712T3 (es) 2011-05-26 2017-11-17 Phoenix Pharmaceuticals, Inc. Péptidos de foenixina
EP2541252A1 (de) * 2011-06-30 2013-01-02 B.R.A.H.M.S GmbH Verfahren zum Erhalten eines Binders für Preprovasopressin oder Fragmente davon
CA2854563A1 (en) * 2011-11-11 2013-05-16 Woomera Therapeutics Provasopressin antagonists and uses thereof
GB201210686D0 (en) 2012-06-15 2012-08-01 Holsboermaschmeyer Neurochemie Gmbh V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
GB201310782D0 (en) 2013-06-17 2013-07-31 Max Planck Innovation Gmbh Method for predicting a treatment response to a CRHR1 antagonist and/or V1B antagonist in a patient with depressive and/or anxiety symptoms
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
EP3256858B1 (de) 2015-02-10 2020-03-25 B.R.A.H.M.S GmbH Histon h4 peptid als biomarker
EP3279667A1 (de) 2016-08-02 2018-02-07 Abbott Laboratories Herz-troponin i und copeptin als biomarker für kurzfristige sterblichkeit bei akuter exazerbation von chronisch obstruktiver lungenerkrankung (aecopd)
CN109061140A (zh) * 2018-08-31 2018-12-21 广州华澳生物科技有限公司 一种和肽素免疫层析检测试剂卡及其制备方法
CN109596839A (zh) * 2018-12-25 2019-04-09 广州万孚生物技术股份有限公司 人和肽素快速定量检测方法与试剂盒
CN109679924A (zh) * 2018-12-25 2019-04-26 广州万孚生物技术股份有限公司 高亲和力抗人和肽素的单克隆抗体及其制备方法与应用
WO2020156988A1 (en) * 2019-01-28 2020-08-06 B.R.A.H.M.S Gmbh Method to predict treatment response in patients with nocturnal enuresis
CN111007270A (zh) * 2019-11-27 2020-04-14 迪瑞医疗科技股份有限公司 和肽素化学发光免疫检测试剂盒及其制备方法
CN113406339A (zh) * 2021-08-19 2021-09-17 山东康华生物医疗科技股份有限公司 一种干式免疫荧光定量法人和肽素（cpp）检测试剂盒

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413783B1 (en) * 1997-09-18 2002-07-02 Meso Scale Technologies, Llc Assay sonication apparatus and methodology
AU2001271589A1 (en) * 2000-06-30 2002-01-14 Zymogenetics Inc. Mammalian secreted proteins
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
CN1166953C (zh) * 2001-05-30 2004-09-15 上海晶泰生物技术有限公司 一步法多指标检测心肌梗塞的快速金标检测试剂盒
KR20040058324A (ko) * 2001-11-26 2004-07-03 다이이찌 산토리 파마 가부시키가이샤 경비흡수용 의약 조성물
WO2004006860A2 (en) * 2002-07-16 2004-01-22 Woomera Therapeutics, Inc. Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
AU2003300407A1 (en) * 2002-12-24 2004-07-22 Biosite Incorporated Method and system for disease detection using marker combinations
WO2008049422A2 (de) * 2006-10-26 2008-05-02 Brahms Aktiengesellschaft Risikostratifizierung des akuten koronarsyndroms mittels fragmenten / teilpeptiden des provasopressins, insbesondere copeptin oder neurophysin ii
DE102006053442A1 (de) * 2006-11-12 2008-05-15 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Infektionen und chronischen Erkrankungen der Atemwege und Lunge mittels proVasopressin, insbesondere Copeptin oder Neurophysin II
DE102006060112A1 (de) * 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
DE102007010834A1 (de) * 2007-03-03 2008-09-04 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Herzinsuffizienz für NYHA I Patienten

Also Published As

Publication number Publication date
US20110008911A1 (en) 2011-01-13
CN102539789B (zh) 2015-04-08
MXPA06014775A (es) 2007-03-23
ES2296224T3 (es) 2008-04-16
WO2006018315A1 (en) 2006-02-23
EP1628136A1 (de) 2006-02-22
CN102539789A (zh) 2012-07-04
CN101010591A (zh) 2007-08-01
EP1738178A1 (de) 2007-01-03
ATE375518T1 (de) 2007-10-15
US20090221009A1 (en) 2009-09-03
JP2011227095A (ja) 2011-11-10
HK1172690A1 (en) 2013-04-26
JP4932714B2 (ja) 2012-05-16
US7807397B2 (en) 2010-10-05
HK1114171A1 (en) 2008-10-24
EP1738178B1 (de) 2007-10-10
CN101010591B (zh) 2011-12-21
DE602005002836T2 (de) 2008-07-31
AR050215A1 (es) 2006-10-04
JP2008510151A (ja) 2008-04-03
US20170242037A1 (en) 2017-08-24

Similar Documents

Publication Publication Date Title
DE602005002836D1 (de) Diagnoseverfahren für erkrankungen unter verwendung von copeptin
DE602005001895D1 (de) Abnehmbare Prüfspitze für Abtastsystem
DE602005018414D1 (de) Betätigungseinrichtung für ein endoskopisches Gerät zum Anbringen von Klammern
DE602006017421D1 (de) Screening-verfahren für kokumi-vermittelnde agentien
DK1748077T3 (da) Fremgangsmåde til fremstilling af protein
DE602006013447D1 (de) Uerverfahren für leistungsabgabevorrichtung
DE602005003147D1 (de) Messsystem
FR2873096B1 (fr) Avion multimoteur
DE602005027610D1 (de) Nmr-gyroskop
DE602004011334D1 (de) Rüttler für Zellkulturklimaschrank
DE602004027424D1 (de) Operationsverwaltungsprogramm, operationsverwaltun
ME01459B (me) Postupak za doziranje medikamenata
DE602005021793D1 (de) Abgasrückführungssystem unter verwendung von unein
DE102004001078B8 (de) Flugzeugrumpf
DE602006009513D1 (de) Verwendung von phenylsemicarbazonen für die saatgutbeizung
ATE448234T1 (de) Olanzapin-analoga und verfahren zu ihrer verwendung
DE202005001541U1 (de) Membranen für Brennstoffzellen und Brennstoffzellen unter Verwendung derartiger Membranen
DE602005003123D1 (de) Radaraltimeter für hängelasttransportierende helikopter
DK1789800T3 (da) Ileitis-diagnosetest
DE502005000300D1 (de) Tastkopf
DE602005020180D1 (de) Verbessertes messsystem
ITMI20052509A1 (it) Assemblati per dispositivi elettrochimici
DE60314525D1 (de) Reset-Modus für Scan-Test-Modi
DE602005025919D1 (de) Herstellungsverfahren für azopigmentdispersion
DE102005033690A8 (de) Dichtungsaufbau für Keramikheizung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: B.R.A.H.M.S GMBH, 16761 HENNIGSDORF, DE